此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Association Between Bilateral Intermediate Cervical Plexus Block and Salivary Biomarkers of Surgical Stress Response Following Total Thyroidectomy

2026年7月20日 更新者:Antonija Mihelcic、University Hospital Dubrava

The aim of this study is to evaluate how an ultrasound-guided bilateral intermediate cervical plexus block affects the surgical stress response in individuals undergoing total thyroidectomy. The primary objective is to quantify this physiological response through the analysis of specific stress and inflammatory biomarkers collected from the participants' saliva.

The clinical trial will encompass a total of 48 patients, randomized equally into two distinct cohorts of 24 participants each. The control group will undergo standard total intravenous anesthesia (TIVA), whereas the experimental group will receive the bilateral intermediate cervical plexus block in combination with the TIVA protocol.

It is hypothesized that integrating this regional nerve block with total intravenous anesthesia will significantly attenuate the surgical stress response, evidenced by a reduction in salivary biomarker concentration, compared to utilizing TIVA alone during thyroid surgery.

Validating this hypothesis would offer robust scientific evidence to advocate for the routine integration of the bilateral intermediate cervical plexus block into standard anesthetic practices for total thyroidectomy. Ultimately, this approach aims to minimize perioperative stress and facilitate a more rapid postoperative recovery for patients.

研究概览

研究类型

介入性

注册 (估计的)

48

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • ASA I or ASA II
  • euthyroid status
  • signed informed consent

Exclusion Criteria:

  • patients who refuse to sign the informed consent form
  • infection at the block injection site
  • hypersensitivity or contraindications to the medication used in the study
  • hypo/hyperthyroidism at the time of surgery
  • presence of substernal goiter
  • additional surgical interventions during the procedure
  • history of previous neck surgery or radiation
  • coagulopathy
  • uncontroled respiratory disease
  • diabetes mellitus
  • autoimune disease
  • chronic corticosteroid therapy
  • smokers
  • pregnant women

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
无干预:TIVA alone
实验性的:TIVA + bilateral intermediate cervical plexus block with 0,25% levobupivacaine

Following the induction of general anesthesia in the study group, an ultrasound-guided bilateral intermediate cervical plexus block will be performed.

The cervical plexus is visualized on the screen as a small cluster of hypoechoic nodules beneath the posterolateral border of the sternocleidomastoid muscle and immediately above the prevertebral fascia. After sterile preparation, a 22-gauge needle is inserted under ultrasound guidance in a lateromedial direction. The needle tip is positioned within the specified space, approximately 2 cm medial to the skin entry point. Following a negative aspiration test, 10 mL of 0.25% levobupivacaine is injected and visualized on the ultrasound screen. The same procedure will be repeated on the contralateral side.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Salivary IL-6 Concentration
大体时间:Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery
Unit of measure: pg/mL
Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery
Salivary Cortisol Concentration
大体时间:Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery
Unit of measure: nmol/L
Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery
Salivary Alpha-amylase Activity
大体时间:Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery
Unit of measure: U/L
Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery

次要结果测量

结果测量
措施说明
大体时间
Total Intraoperative Sufentanyl Consumption
大体时间:Intraoperative period
Unit of measure: mcg/kg/min
Intraoperative period
Total Postoperative Analgetics consumption
大体时间:During the first 24 hours after the completion of surgery
Unit of measure: mg
During the first 24 hours after the completion of surgery
Time to Rescue Analgesia
大体时间:During the first 24 hours after the completion of surgery
Unit of measure: minutes
During the first 24 hours after the completion of surgery
Hemodynamic Stability (heart rate)
大体时间:Intraoperative period and during the first 24 hours after the completion of surgery
Heart rate will be recorded during the resaerch period. Unit of measure: beats/minute
Intraoperative period and during the first 24 hours after the completion of surgery
Postoperative Sedation Level
大体时间:During the first 4 hours after the completion of surgery
Postoperative seadtion level will be mesured by Richmond Agitation-Sedation Scale ranging from -5 (deepely sedated) to +4 (highly agitated), with 0 being completely alert and calm.
During the first 4 hours after the completion of surgery
Postoperative Nausea and Vomiting
大体时间:During the first 24 hours after the completion of surgery
The incidence of postoperative nausea and vomiting will be determined
During the first 24 hours after the completion of surgery
Hemodynamic Stability (blood pressure)
大体时间:Intraoperative period and during the first 24 hours after the completion of surgery

Systolic, diastolic and mean arterial pressure will be recorded during the research peroid.

Unit of measure: mmHg

Intraoperative period and during the first 24 hours after the completion of surgery

其他结果措施

结果测量
措施说明
大体时间
Incidence of block complication
大体时间:From the administration of the block up to 48 hours after the completion of surgery
The incidence of possible complication of the block will be determined.
From the administration of the block up to 48 hours after the completion of surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2027年2月1日

研究完成 (估计的)

2027年4月1日

研究注册日期

首次提交

2026年7月8日

首先提交符合 QC 标准的

2026年7月20日

首次发布 (实际的)

2026年7月23日

研究记录更新

最后更新发布 (实际的)

2026年7月23日

上次提交的符合 QC 标准的更新

2026年7月20日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • 0119-04-01

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅